# NICE

Type: organization

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/nice
Canonical HTML page: https://gethealthbrief.com/entity/nice

## Timeline

- **2026-04-01**: Expected Appeal Date — Final appraisal committee meeting to review new evidence and potential Managed Access Agreements.
- **2026-03-06**: National Campaign Launch — Bereaved family and patient advocates launch a coordinated media campaign imploring the NHS to reconsider.
- **2026-01-15**: NICE Initial Review — NICE issues a preliminary recommendation against routine funding based on cost-effectiveness.
- **2025-11-12**: MHRA Approval — The drug receives safety and efficacy licensing for use in the UK market.

## Recent coverage (1 stories)

### NHS Faces Mounting Pressure to Approve High-Efficacy Cancer Therapies
2026-03-06 01:31:00 · Sentiment: Negative · Impact: 7/10 · Sources: 11

A bereaved family's national campaign has ignited a fierce debate over the NHS's refusal to fund a new treatment for aggressive cancer despite evidence of significant tumor shrinkage. The case underscores the growing tension between rapid pharmaceutical innovation and the UK's rigid cost-effectiveness appraisal frameworks.
Full story: https://gethealthbrief.com/story/nhs-regulatory-pressure-aggressive-cancer-treatment

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.